Novartis (NVS) Stock Statistics & Valuation Metrics

Novartis has a market cap or net worth of $204.06B. The enterprise value is ―.

Novartis has 2,112,421,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Novartis’s return on equity (ROE) is 0.27 and return on invested capital (ROIC) is 15.55%.

The current PE Ratio of Novartis is 16.45. Novartis’s PEG ratio is 2.03.

In the last 12 months, Novartis had revenue of 51.72B and earned 11.94B in profits. Earnings per share was 5.92.

In the last 12 months, operating cash flow was 19.00B and capital expenditures -4.15B, giving a free cash flow of 14.85B billion.

Novartis pays an annual dividend of $2.515, resulting in a dividend yield of 3.02%

Novartis upcoming earnings date is Jul 17, 2025, TBA Not Confirmed.

Novartis as a current ratio of 1.04, with Debt / Equity ratio of 81.50%

In the past 12 months, Novartis has paid 1.70B in taxes.

Novartis EV to EBITDA ratio is 10.44, with an EV/FCF ratio of 15.66.

Novartis has $7.20B in cash and marketable securities with $31.27B in debt, giving a net cash position of $24.07B billion.

Gross margin is 75.40%, with operating margin of 28.12%, and net profit margin of 23.09%.

The average price target for Novartis is $107.00, which is 11.43% higher than the current price. The consensus rating is Hold